Lecigon, Gel zur intestinalen Anwendung

7680683600013 CH-68360 Gel zur intestinalen Anwendung

Associated product:

LECIGON gel 7 x 47 ml
Lecigon, Gel zur intestinalen Anwendung
Lecigon, Gel zur intestinalen Anwendung
Lecigon, Gel zur intestinalen Anwendung
1 / 3
google

Article details

Package size
7 x 47
Selling units
7
Measure
ml
Galenic form
Gel zur intestinalen Anwendung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2026
Patient information leaflet
Français
26/09/2026
Patient information leaflet
Italien
26/09/2026
Summary of Product Characteristics
Allemand
26/09/2026
Summary of Product Characteristics
Français
26/09/2026
Summary of Product Characteristics
Italien
26/09/2026

Detailed composition

Substance Quantity Type Category
levodopum
20.0 MG Substance Wirkstoff (Principe actif)
carbidopum monohydricum
5.0 MG Substance WIZUS
carbidopum
4.6 MG Substance Wirkstoff (Principe actif)
entacaponum
20.0 MG Substance Wirkstoff (Principe actif)
carmellosum natricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 423.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68360
Drug name
Lecigon, Gel zur intestinalen Anwendung
Galenic form
GELIA
ATC Code
N04BA03
Authorization status
Z
Dispensing category
B
First authorization
02/02/2022
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine
Field of application
Behandlung der fortgeschrittenen Parkinson-Krankheit

Package details

Description (FR)
LECIGON gel 7 x 47 ml
Description (DE)
LECIGON Gel 7 x 47 ml
Market launch
02/02/2022
Narcotic (BTM)
No
Buy us a coffee Explore the data